Pages that link to "Q69403118"

The following pages link to Plant antitumor agents. 25. Total synthesis and antileukemic activity of ring A substituted camptothecin analogues. Structure-activity correlations (Q69403118):

Displaying 22 items.

• Camptothecins: a review of their chemotherapeutic potential (Q28203339) (← links)
• The structure–activity relationships of A-ring-substituted aromathecin topoisomerase I inhibitors strongly support a camptothecin-like binding mode (Q29028715) (← links)
• Activity of Indenoisoquinolines against African Trypanosomes (Q29041290) (← links)
• Topoisomerase-I inhibitors in gynecologic tumors (Q33541928) (← links)
• In-vitro Cellular Uptake and Transport Study of 9-Nitrocamptothecin PLGA Nanoparticles Across Caco-2 Cell Monolayer Model (Q35046472) (← links)
• Comparison of two self-assembled macromolecular prodrug micelles with different conjugate positions of SN38 for enhancing antitumor activity (Q35223416) (← links)
• Biodistribution and pharmacokinetics of colon-specific HPMA copolymer--9-aminocamptothecin conjugate in mice (Q35729242) (← links)
• Identification, synthesis, and biological evaluation of metabolites of the experimental cancer treatment drugs indotecan (LMP400) and indimitecan (LMP776) and investigation of isomerically hydroxylated indenoisoquinoline analogues as topoisomerase I (Q36525254) (← links)
• Cancer therapies utilizing the camptothecins: a review of the in vivo literature (Q37069556) (← links)
• Progress in nanotechnology based approaches to enhance the potential of chemopreventive agents (Q38161333) (← links)
• A camptothecin-resistant DNA topoisomerase I mutant exhibits altered sensitivities to other DNA topoisomerase poisons (Q38297510) (← links)
• Current perspectives on camptothecins in cancer treatment (Q42715927) (← links)
• Analysis of stereoelectronic properties of camptothecin analogues in relation to biological activity (Q43506846) (← links)
• The highly lipophilic DNA topoisomerase I inhibitor DB-67 displays elevated lactone levels in human blood and potent anticancer activity. (Q43698671) (← links)
• A mechanistic and kinetic study of the E-ring hydrolysis and lactonization of a novel phosphoryloxymethyl prodrug of camptothecin (Q44525190) (← links)
• Stability of the new prodrug 9-aminocamptothecin glucuronide (9ACG) in the presence of human serum albumin (Q44593849) (← links)
• Camptothecin (CPT) and its derivatives are known to target topoisomerase I (Top1) as their mechanism of action: did we miss something in CPT analogue molecular targets for treating human disease such as cancer? (Q47220295) (← links)
• Kinetics of lactone hydrolysis in antitumor drugs of camptothecin series as studied by fluorescence spectroscopy. (Q53956545) (← links)
• The Important Role of Albumin in Determining the Relative Human Blood Stabilities of the Camptothecin Anticancer Drugs (Q71943656) (← links)
• The role of pH and serum albumin in the metabolic conversion of 9‐nitrocamptothecin to 9‐aminocamptothecin by human hematopoietic and other cells (Q72052170) (← links)
• Camptothecins: a review of their development and schedules of administration (Q77809113) (← links)
• Absorption of 10-hydroxycamptothecin on Fe3O4 magnetite nanoparticles with layer-by-layer self-assembly and drug release response (Q83424948) (← links)